Protease inhibitors and cardiovascular outcomes in patients with HIV-1

@article{Holmberg2002ProteaseIA,
  title={Protease inhibitors and cardiovascular outcomes in patients with HIV-1},
  author={Scott Holmberg and Anne C. Moorman and John M. Williamson and Tony C Tong and the HIV Outpatient Study investigators},
  journal={The Lancet},
  year={2002},
  volume={360},
  pages={1747-1748}
}
Protease inhibitors for treatment of HIV-1 have been linked with increased risk of hyperlipidaemia and hyperglycaemia. In a cohort of 5672 outpatients with HIV-1 seen at nine US HIV clinics between January, 1993, and January, 2002, the frequency of myocardial infarctions increased after the introduction of protease inhibitors in 1996 (test for trend, p=0.0125). We noted that 19 of 3247 patients taking, but only two of 2425 who did not take, protease inhibitors had a myocardial infarction (odds… CONTINUE READING
Highly Influential
This paper has highly influenced 12 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 155 extracted citations

Cardiovascular toxicity with highly active antiretroviral therapy

Cardiovascular Toxicology • 2007
View 8 Excerpts
Highly Influenced

Risk of cardiovascular disease & diabetes mellitus in Danish HIV-infected individuals

PH.D. THESIS, Line Dahlerup
2015
View 4 Excerpts
Highly Influenced

HIV and coronary heart disease: time for a better understanding.

Journal of the American College of Cardiology • 2013
View 2 Excerpts
Highly Influenced

HIV and HAART-Associated Dyslipidemia

The open cardiovascular medicine journal • 2011
View 12 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…